In these data sets, ARHGAP29 mRNA expression appeared enriched in glomerular diseases usually presenting with milder damage patterns such as hypertensive nephropathy (HTN) and minimal change disease (MCD). Here, ARHGAP29 is linked to glomerular disorder.